Chikungunya Vaccination Urged in Reunion
Reunion Island Expands Chikungunya Vaccination Amid Epidemic
Table of Contents
- Reunion Island Expands Chikungunya Vaccination Amid Epidemic
- Vaccination Recommendations Broadened
- Minister Valls Supports Vaccination Efforts
- Campaign Adjusted After Adverse Reactions
- Chikungunya Outbreak Impact
- Epidemic’s toll on Reunion
- Rising Death Toll and Stabilization Concerns
- Past Outbreaks and Current Situation
- Minister’s Warning
- Chikungunya Vaccination in Reunion Island: Your Questions Answered
- What’s happening on Reunion Island regarding Chikungunya?
- Who is now eligible for the chikungunya vaccine?
- What health conditions qualify someone for vaccination?
- What is Chikungunya and how is it spread?
- What are the symptoms of Chikungunya?
- Is there a cure for Chikungunya?
- What vaccine is being used on Reunion Island?
- What do health officials and ministers say about the vaccination campaign?
- Has the vaccination campaign faced any challenges?
- What is the current impact of the chikungunya outbreak? (As of April 2025)
- How does the current outbreak compare to past outbreaks on Reunion Island?
- What are the key takeaways from the Chikungunya situation on Reunion Island?
- What preventive measures are recommended?
SAINT-DENIS, Reunion Island – Health officials on Reunion Island are urging residents to get vaccinated against chikungunya as the island grapples with a significant outbreak. The vaccination campaign, initially focused on seniors, has been broadened to include adults aged 18-65 with certain health conditions.
Vaccination Recommendations Broadened
Health Minister Yannick Neuder, speaking on France 3, emphasized the importance of vaccination for individuals with pre-existing conditions.”If you have renal failure, heart or respiratory failure, diabetes, or obesity, and are between 18 and 65, vaccination is recommended,” Neuder stated.
Minister Valls Supports Vaccination Efforts
Overseas Minister Manuel Valls,appearing on RTL/M6/Le figaro/Public Senate,expressed confidence in the health authorities’ approach. “I trust the health authorities,” Valls said, noting the novelty of this vaccine. “This is the first time that a vaccine has been used against chikungunya.”
Campaign Adjusted After Adverse Reactions
The vaccination campaign, launched weeks prior with a focus on the elderly, was quickly adjusted after three individuals over 80 with comorbidities experienced “serious adverse events,” according to Valls. Despite these incidents, Valls affirmed the campaign’s continuation, stating that “recommendations have been given.” He also refuted claims of rushing the vaccine’s rollout, pointing out that the IXCHIQ vaccine received marketing authorization in June 2024.
Chikungunya Outbreak Impact
Chikungunya, transmitted by the tiger mosquito, causes high fever and debilitating joint pain that can persist for weeks. Currently, there is no specific cure for the disease.
Epidemic’s toll on Reunion
Health authorities initiated the vaccination campaign in early April in response to a widespread epidemic. The IXCHIQ vaccine is the first to receive marketing authorization in Europe for chikungunya prevention.
Rising Death Toll and Stabilization Concerns
As of Wednesday,health officials reported nine deaths attributed to the chikungunya epidemic. While the epidemic “stabilizes at a high level,” concerns remain about the overall impact.
Past Outbreaks and Current Situation
The current outbreak began in August 2024,with cases surging in march 2025. Before this, Reunion Island had not reported any chikungunya cases since 2010. A major epidemic between 2005 and 2006 affected approximately 260,000 people and resulted in over 200 deaths.
Minister’s Warning
“The assessment is already heavy and can obviously worsen,” warned Valls, emphasizing the need for preventive measures.
Published: April 27, 2025
Chikungunya Vaccination in Reunion Island: Your Questions Answered
What’s happening on Reunion Island regarding Chikungunya?
Reunion Island is currently facing a meaningful chikungunya outbreak. Health officials are urging residents to get vaccinated to combat the spread of the disease. The vaccination campaign has been expanded to include a wider range of adults.
Who is now eligible for the chikungunya vaccine?
initially focused on seniors, the vaccination campaign on Reunion Island now includes adults aged 18-65 with specific health conditions.
What health conditions qualify someone for vaccination?
health Minister Yannick Neuder has recommended vaccination for individuals aged 18-65 who have the following pre-existing conditions:
respiratory failure
Diabetes
Obesity
What is Chikungunya and how is it spread?
chikungunya is a viral disease transmitted by the tiger mosquito.
What are the symptoms of Chikungunya?
Chikungunya causes:
High fever
* Debilitating joint pain.
This joint pain can persist for weeks.
Is there a cure for Chikungunya?
Currently, there is no specific cure for Chikungunya.
What vaccine is being used on Reunion Island?
The IXCHIQ vaccine is being used in the vaccination campaign on Reunion Island.
What do health officials and ministers say about the vaccination campaign?
Overseas Minister Manuel Valls expressed confidence in the health authorities’ approach, emphasizing that this is the first time a vaccine has been used against chikungunya. Health officials are urging residents to get vaccinated.
Has the vaccination campaign faced any challenges?
Yes, the campaign was adjusted after three individuals over 80 with comorbidities experienced “serious adverse events.” Recommendations have been given in response to these events. Minister Valls has stated that the rollout was not rushed,given the marketing authorization date of June 2024 for the IXCHIQ vaccine.
What is the current impact of the chikungunya outbreak? (As of April 2025)
As of Wednesday, health officials reported nine deaths attributed to the chikungunya epidemic. While the epidemic “stabilizes at a high level,” concerns about the overall impact remain.
How does the current outbreak compare to past outbreaks on Reunion Island?
The current outbreak began in August 2024, with cases surging in March 2025. Before this, Reunion Island had not reported any chikungunya cases as 2010. A major epidemic occurred between 2005 and 2006, affecting approximately 260,000 people and resulting in over 200 deaths.
What are the key takeaways from the Chikungunya situation on Reunion Island?
| Feature | Details |
| ——————– | ——————————————————————————————————————————————————————— |
| Current Status | Significant outbreak; vaccination campaign underway. |
| Vaccine | IXCHIQ vaccine.|
| target Groups | Adults aged 18-65 with certain health conditions, and initially the elderly. |
| Key Symptoms | High fever and debilitating joint pain.|
| Mortality (April 2025) | Nine deaths reported. |
| Past Outbreaks | Major epidemic in 2005-2006, affecting 260,000+ people and resulting in over 200 deaths. |
| Spread | Transmitted through the tiger mosquito. |
What preventive measures are recommended?
Minister Valls has warned that the assessment is already heavy and can worsen, emphasizing the need for preventive measures.